Breast cancer study checks if patients stay on treatment
Knowledge-focused
Recruiting now
This study looks at how often patients with high-risk early breast cancer keep taking the drug abemaciclib after 6 months. Researchers will review past treatment records from 200 women to see how many stay on therapy. The goal is to understand real-world adherence, not to test a …
Sponsor: Institut fuer Frauengesundheit • Aim: Knowledge-focused
Last updated May 22, 2026 13:53 UTC